Background sHR 0.221, 95%CI 0.071-0.683; p =0.0087). The median time from TARE to LT was 17 months. In the 37 transplanted patients, post-LT 3-/5-years OS and RFS were 67.2%/61.6% and 79.3%/79.3% respectively. Pathology showed complete tumor necrosis in 56.7% explants. Conclusions: Radioembolization downstaged approximately one in four PVTT patients to transplant eligibility. After downstaging, LT conferred markedly superior oncological outcomes. TARE in PVTT-associated with HCC represents a valid, transplant-oriented option with a distinct efficacy profile.
Sposito et al. (Tue,) studied this question.